Gastrointestinal side effects lead some patients to discontinue treatment, and weight regain after stopping therapy is common
It is a once-weekly injectable medication that combines the effects of two naturally occurring hormones, GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory peptide), to help regulate blood sugar levels and support weight loss
In the multivariate analysis, l-carnitine administration (odds ratio [OR] 3.51, 95% confidence interval [CI] 1.239.99, p = 0.019) and baseline NIRS data of 0.07 mMmm (OR 5.21, 95% CI 1.6916.0, p = 0.0041) were found as independent significant factors
The best medication depends on factors like your health history, how your body responds to treatment, and insurance coverage
You might feel fatigued Fatigue was the second most common side effect for participants in the US clinical trial, affecting 6.3% of participants
Some individuals delay appropriate intensification simply because they fear needles